Clinical Trial Update: Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease [NA]

View source ↗

Summary

This clinical trial update reports a randomized trial of Triptolide Woldifii for autosomal dominant polycystic kidney disease, which was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease
• Polycystic Kidney Disease

Drugs mentioned

• Triptolide Woldifii (Triptolide)

Snippet

Sponsor: Zhi-Hong Liu, M.D. | Conditions: Polycystic Kidney | NA | Status: TERMINATED